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Abstract
Small duplications (miniduplications) of the D-loop of human mitochondrial DNA (mtDNA) have been described in patients with
mtDNA deletions, mtDNA point mutations and in normal aged tissues. The origin of these miniduplications is still unknown but it is
hypothesized that they could be formed after oxidative damage. The respiratory chain (RC) is the main source of free radicals in mitochondria
and it is believed that a defect in RC increases free radical generation. If miniduplications are originated by oxidative damage, it is expected
that they are more abundant in patients with a defect in the RC. We studied the frequency of miniduplications of D-loop in patients with a RC
defect due to mtDNA deletions and in controls. We show that four types of miniduplications could be detected with a higher prevalence than
in previous studies and that patients with mtDNA deletions did not have higher proportions or increased number of miniduplications, which
is against the hypothesis that miniduplications are generated more abundantly in patients with RC defects. We also clearly demonstrate the
age-related nature of these miniduplications by a carefully controlled study regarding the age of subjects, which was not considered in other
studies on patients with a mitochondrial disease.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
An approximate 260-bp tandem duplication in the D-
loop region of human mitochondrial DNA (mtDNA) was
first identified by Brockington et al. [1] and associated with
mtDNA deletions in mitochondrial myopathy. The 260-bp
duplication is a heteroplasmic length polymorphism found
in low abundance and located in the region that controls
replication and transcription of mtDNA (D-loop). Because
of this location and the finding in 31% of patients with
mtDNA deletions (18 out of 58) but not in normal subjects,
it was suggested that this duplication could be relevant to
deletions formation [1]. Since then, other studies did not
confirm a high prevalence of this rearrangement in patients
with mtDNA deletions, finding lower proportions that
varied from 3% to 12% [2–4]. On the other hand, the
260-bp duplication and several other duplications in the D-
loop (miniduplications) were also found in normal aged
individuals [5,6], suggesting that these miniduplications in
D-loop are early molecular events of the human aging
process. More recently, Bouzidi et al. [7] described a 200-
bp tandem duplication with high proportion associated with
a cytochrome b mutation. It was suggested a relationship
between miniduplication formation and respiratory chain
(RC) deficiency, which was explained by a possible increase
in free radical production from the defective RC whether the
genetic origin of the deficiency be a deletion or a point
mutation in the mtDNA [7].
In this study, we explore the idea that formation of
miniduplications could be enhanced by a defective RC in
patients with mtDNA deletions. We show that four types
of miniduplications could be detected by polymerase
chain reaction (PCR) with a higher prevalence than in
previous studies and that patients with mtDNA deletions
did not have higher proportions or increased number of
miniduplications, which is against the hypothesis that
miniduplications are generated more abundantly in pa-
tients with RC defects. We also clearly demonstrate the age-
0925-4439/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
PII: S0925 -4439 (02 )00140 -0
* Corresponding author. Disciplina de Neurologia Clı´nica, Escola
Paulista de Medicina, Universidade Federal de Sa˜o Paulo, R. Pedro de
Toledo, 781, setimo andar, 04039-032, Sa˜o Paulo, SP, Brazil. Tel.: +55-11-
5579-9236; fax: +55-11-5081-5005.
E-mail address: chtengan@neuro.epm.br (C.H. Tengan).
www.bba-direct.com
Biochimica et Biophysica Acta 1588 (2002) 65–70
related nature of this rearrangement by a carefully con-
trolled study regarding the age of the subjects, which was
not considered in other studies with patients with mtDNA
deletions.
2. Materials and methods
2.1. DNA samples
DNA samples were obtained from autopsy material or
muscle biopsies specimens performed exclusively for diag-
nostic purposes. Genomic DNA was isolated with SDS/
proteinase K treatment followed by phenol/chloroform
extraction. We studied samples divided in two groups: (1)
patients group: patients with chronic external ophthalmo-
plegia and single mtDNA deletions (N=24); and (2) control
group: individuals with no abnormalities on muscle histol-
ogy (autopsy material or diagnostic muscle biopsies)
(N=27). Quantification of total DNA was performed in the
VersaFluor fluorometer (BioRad) using the Hoechst dye
assay.
All patients had pathogenic deletions and not large-scale
duplications as determined by a Southern blot study with
different restriction enzymes and two probes according to
Tengan et al. [8].
This study was approved by the Ethics Committee of
Universidade Federal de Sa˜o Paulo and is in accordance
with the ethical standards of the Helsinki Declaration.
2.2. Detection of miniduplications
Miniduplications of the D-loop region were detected by
PCR using 20 pmol of back-to-back primers located at
positions 336–357 and 335–305 of mtDNA (5V!3V) [4],
10 ng of genomic DNA, 20 nmol of each deoxynucleotide
triphosphate (dNTP), 10 PCR buffer, 2.5 units of Taq
DNA polymerase (Amersham-Pharmacia Biotech). PCR
conditions were: 94 jC for 5 min followed by 40 cycles
with 94 jC for 30 s and 60 jC for 30 s. PCR products were
separated by electrophoresis through an ethidium bromide
stained agarose gel and then visualized under a UV source.
A positive control of the reaction was performed using a
DNA sample from cybrid cells containing 100% of the 260-
bp miniduplication [9], kindly provided by Dr. C.T. Moraes.
Positions in mtDNA were numbered according to the
published mtDNA sequence [10].
2.3. DNA sequencing
PCR products encompassing miniduplications were gel
purified according to GeneClean protocol (Bio101) and
subcloned into vector pCRII (Invitrogen). Sequencing reac-
tion was performed according to BigDye Sequencing kit
instructions using M13 Universal primer and run in a ABI
Prism 377 Automated Sequencer (Applied Biosystems).
2.4. Quantitative analyses
The quantitation of miniduplication was performed by
the serial dilution method as previously described [11] with
slight modifications in the PCR conditions. Briefly, 1 Al of
serial 10-fold dilutions was submitted to a short cycle PCR
(40 cycles consisted of 94 jC for 30 s and 60 jC for 30 s).
Two parallel PCR reactions were performed using two pairs
of primers. The first pair of primers flanked the minidupli-
cation (primers as cited above). The second pair of primers
(forward primer from mtDNA position 5472 to 5491 and
reverse primer from mtDNA position 5982 to 5960) ampli-
fied a 510-bp fragment (control fragment) that is present
both in normal and duplicated mtDNA. Ten microliters of
the PCR amplification was submitted to electrophoresis
through an ethidium bromide-stained agarose gel, visualized
and photographed under a UV source. Optical densities
(OD) of the bands were measured by scanning nonsaturated
positive prints and quantifying the pixel density (freeware
package NIH IMAGE 1.57). The OD obtained was plotted
as a function of the template dilutions (the points corre-
sponding to the saturation phase of the PCR amplification
were excluded). A linear regression analysis was performed
to identify the dilution corresponding to the disappearance
of each specific template. The ratio between these dilutions
(minidup ratio) was used to estimate the amount of mini-
duplications in each group (patient and control).
2.5. Phenotype–genotype correlation
The results on detection of miniduplications were corre-
lated with clinical and molecular features of patients. The
features analysed included age, type of clinical presentation,
presence of endocrinopathy, molecular defect (deletion:
size, location, proportion, direct repeats, presence of large
duplication).
2.6. Statistical analyses
Statistical analyses were performed with Statview 5.01
(SAS Institute Inc.). Comparison of means was performed
by the Student’s t-test and statistical significance was set to a
P<0.05.
3. Results and discussion
In order to determine the prevalence of miniduplications,
we studied two groups (patients and controls), formed by
individuals with similar distribution of age, from 11 to 70
years old in controls and from 11 to 66 years old in patients.
PCR was performed with equal amounts of total DNA (10
ng) in both groups and miniduplications were detected in 17
(63%) controls and 14 (58%) patients. The higher frequency
of miniduplications detected in our study could be explained
by the use of different PCR conditions leading to a more
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efficient amplification. We detected four different bands that
corresponded to duplications of approximately 150, 190,
260 and 650 bp (Fig. 1). The 190-bp duplication was the
same duplication described by Lee et al. [5]. The other
duplications had similar sizes to the ones described previ-
ously [1,2,4,5,7], but the exact breakpoints were slightly
different. Although the 260-bp duplication was the first one
to be described [1], it was not the most frequent, in fact it
appeared in only two (9%) patients and six (20%) controls
(Table 1). The 650-bp miniduplication was the most fre-
quent in both groups, found in 48% of patients and 37% of
controls. Some patients and controls presented two or three
types of miniduplications at the same time. We detected
only one band in seven patients and nine controls, and two
or three bands in seven patients and eight controls. The
number of bands obtained were not statistically different
between both groups, but we observed that one band was
obtained in individuals with age around 30 years and two or
more bands around 50 years, suggesting an increase in the
number of miniduplications with age (Fig. 2). A clear
correlation between the presence of miniduplication and
age could be observed when we analysed the age of the
individuals with and without miniduplications. Minidupli-
cations were detected mostly in patients and controls with
higher ages (P<0.001), 40 years for patients (mean=40.4,
S.E.=4.2) and controls (mean=40.1, S.E.=3.6). Samples
without miniduplications had a mean age of 18.1 years
(SE=2.6) for controls and 20.7 years (SE=2.7) for patients
(Fig. 3). Previous studies on patients with mitochondrial
diseases and miniduplications did not consider the age of the
patients as a factor for the presence of miniduplications [1–
4,7]. However, when the age of the subject is informed, we
could observe that they were older than 35 years in those
studies: 67 [1], 58 [4], 35 and 42 years [7].
The main proposed mechanism for the generation of
duplications in the D-loop is by slipped strand mispairing
during replication [12–14]. Analysis of nucleotide sequen-
ces at the breakpoint region demonstrated that duplications
occurred in regions with polycytosine stretches and perfect
direct repeats varying from 5 to 11 nucleotides (Fig. 1).
Fig. 1. Detection of four types of miniduplications of the D-loop. PCR was
performed with back-to-back primers located at positions 336–357 and
335–305 of mtDNA (5V!3V). This pair of primers can only amplify a
fragment if there is a duplicated region (A). Miniduplications in the D-loop
of mtDNAwere observed in 17 (63%) controls and 14 (58%) patients. Four
different bands could be detected after electrophoresis through a 1%
agarose gel: 150, 190, 260 and 650 bp (B). The ages of the individuals are
showed at the top of the gel. Panel C shows the breakpoint region of each
type of miniduplication. Nucleotide positions are indicated above and
below the sequence and direct repeats are underlined. There was an
insertion of a cytosine (*) just before the guanine at nucleotide position 316.
Table 1
Detection of four types of miniduplications in patients and controls
150 bp
(%)
190 bp
(%)
260 bp
(%)
650 bp
(%)
Total
(%)
Patient 5 (24) 4 (19) 2 (9) 10 (48) 21 (100)
Control 4 (13) 9 (30) 6 (20) 11 (37) 30 (100)
Total 9 13 8 21 49
Fig. 2. Number of bands detected in patient and control groups. The primers
used for the amplification of miniduplications amplified one, two or three
bands in the same patient. The graph demonstrates that the number of bands
detected was not increased in the patients but two or more bands were
detected in patients and controls with more than 40 years of age.
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Another interesting feature was that one of the ends of the
duplicated segment occurred in the same region in all four
types, around nucleotide positions 306–316. This region
corresponds to CSB2 (conserve sequence block II) and may
represent a hot spot for this type of rearrangement.
Because of the hypothesis that these duplications could
arise from oxidative damage favoured by a defective RC [7],
we could expect that the appearance of miniduplications
would be earlier in patients with mtDNA deletions. However,
we did not confirm this expectation since the mean age of
patients with duplications were the same in both groups.
Furthermore, we could not find increased variety nor quan-
tity of miniduplications detected in the patients group.
Quantitation was performed in a total of eight patients and
eight controls with similar ages. After obtaining the minidup
ratio, the comparison between patients and controls showed a
slight tendency of higher values for the patient group but this
difference was not statistically significant (Fig. 4). Minidup
ratio indicates the level of miniduplications in relation to a
control amplification and was used to compare the amount of
miniduplications in the patient and control groups. Minidu-
plications could not be detected by Southern blot (data not
shown), demonstrating that they were present in very low
levels in skeletal muscle, only detectable by PCR.
Brockington et al. [1] suggested that the presence of the
duplication in the D-loop could increase the likelihood of
slip replication and hence deletion. In that study, all the
patients with miniduplications had deletions flanked by
direct repeats and in one without flanking repeats the
duplication was not present. The presence of miniduplica-
tion was not more frequent in patients and our results did
not demonstrate an association between presence of direct
repeats and presence of miniduplication. Among 12 patients
with deletions flanked by direct repeats, 7 did not present
miniduplications of the D-loop. There was also one patient
with a miniduplication but no direct repeats. We could not
find any other features of the mtDNA deletion that could be
associated with the presence of miniduplications, such as
location, proportion, presence of a large duplication and any
correlation with other clinical features (Table 2).
Our study demonstrated that miniduplications of the D-
loop of mtDNA are age-related rearrangements but are not
increased in patients with a RC defect. The first age-related
mtDNAmutation described and one of the most studied is the
4977 bp deletion of mtDNA [15]. This deletion can be
present at high percentages in patients with mitochondrial
myopathies [16], but it is also found in very low levels (less
than 1%) in aged postmitotic tissues [11]. Other mtDNA
deletions [17,18] and more recently several point mutations
in D-loop [19] were also detected in aged tissues. The main
mechanisms proposed for the appearance of these mutations
are due to oxidative damage from free radicals generated in
the RC [20]. This hypothesis is supported by the following
evidences: increased production of 8-OH dG with age,
increase in the levels of mtDNA mutations with age, in-
Fig. 4. Quantitative analysis of miniduplications in patients and controls.
(A) The amount of miniduplications was estimated by the minidup ratio, as
described in Materials and methods. We studied two groups, eight patients
and eight age-matched controls with similar age distributions, ranging
between 11 and 57 years. (B) Because minidup ratio is related to age in an
exponential manner, the values were expressed as log minidup ratio to
normalize the data and to better visualize the distribution of the results. The
graph demonstrates that there was a slight tendency of increased values in
the patient group but there was not statistical significant difference between
both groups. Horizontal lines represent the mean values.
Fig. 3. Correlation of age and the presence of miniduplication.
Miniduplications were detected mostly in patients and controls with higher
ages ( P<0.001), 40 years for patients (mean=40.4, S.E.=4.2) and controls
(mean=40.1, S.E.=3.6). Samples without miniduplications had a mean age
of 18.1 years (S.E.=2.6) for controls and 20.7 years (S.E.=2.7) for patients.
No difference could be detected between patients and controls.
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creased susceptibility of mtDNA compared to nuclear DNA,
proximity of mtDNA to a continuous source of free radicals
(RC), decrease of RC activity with age [21–24]. Bouzidi et
al. [7] proposes that single-strand breaks, due to free radical
damage combined with mispairing could explain the gener-
ation of miniduplications at the level of repeated sequences,
which are relatively close to each other in the mtDNA D-
loop. It is supposed that a defect of RC would increase the
leakage of reactive oxygen species from the electron transfer
chain. Free radicals induce secondary mtDNA mutations
exacerbating mitochondrial respiratory defects, creating a
vicious cycle [22]. Although, very attractive, the vicious
cycle theory is an unproven hypothesis and it is still not
determined whether age-related mtDNA mutations are gen-
erated by reactive oxygen species-mediated damage [25].
Based on this theory, we would expect an increase in age-
related mtDNA mutations in patients with RC defects caused
by high proportions of mtDNA deletions, specially consid-
ering that high production of lipid peroxides and 8-OHdG
were found in cybrids harbouring high levels of deleted
mtDNA [26]. Our results do not support this theory and are
in agreement with our previous observation that mtDNA age-
related deletions were not increased in patients with mito-
chondrial diseases caused by mtDNA point mutations [27].
Although it is clear that age-related mtDNA mutations
accumulate during life, their contribution to the aging process
is still not confirmed. Pathogenicity of miniduplications in
the D-loop was not demonstrated in a study of cells homo-
plasmic for the 260-bp duplication [9]. Moreover, similar
insertions in mtDNA control region were also found in other
animals, such as rabbit [12] and monkey [28], suggesting that
errors in mtDNA replication, leading to insertions, can occur
during normal life.
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